Science before Trends
Why We Don’t Chase Trends in Cosmetic Medicine
In cosmetic medicine, trends move fast.
Faster than clinical trials.
Faster than regulatory guidance.
Faster than long-term safety data.
At The Cosmetic Clinic, we see trends early. Often before they reach social media. We watch interest build, we hear patient questions, we see providers begin to experiment.
And then we pause.
Not because we are behind but because we are paying attention. And we care.
The Trend Cycle We See Again and Again
There is a familiar loop in aesthetic medicine:
A new treatment or injectable gains attention
Early anecdotal results circulate
Marketing accelerates faster than evidence
Widespread use begins
Science and safety data eventually catch up
Sometimes, when that data arrives, it confirms the treatment is safe and effective.
Sometimes, it doesn’t.
Our responsibility is to wait for step five before offering step three.
That means we may not offer something right away. And that is very much on purpose.
Safety First. Evidence Always.
Every service we offer must meet two criteria:
Is it safe?
Is there credible, repeatable evidence that it works as intended?
If the answer to either is unclear, we wait.
That decision is not always popular. It is not always profitable. But it is how we protect our patients and our standards.
Examples of Trends We Have Watched Carefully
Here are a few examples where we observed interest early, reviewed the science closely, and made deliberate decisions rather than following momentum.
Exosomes
Exosomes generated significant excitement due to their theoretical regenerative potential. However, current formulations, sourcing inconsistencies, regulatory concerns, and lack of standardized clinical evidence raised important safety and efficacy questions. Until there is clearer data and regulatory alignment, we choose caution.
PDRN
Heard of Salmon Sperm? PDRN has promising mechanisms and is widely discussed, but clinical outcomes, dosing standards, and long-term safety data vary significantly depending on formulation and use. There is also the issue of non compatible animal material. This is an area we continue to monitor closely rather than rush into.
Injectable NAD
We previously offered injectable NAD. When emerging evidence raised concerns around efficacy, tolerability, and better alternatives, we made the decision to stop. Science evolves. Responsible clinics evolve with it. We now prioritize approaches with stronger support and better patient outcomes.
Certain IV Therapies
Not all IVs are created equal. Some formulations lack strong evidence, appropriate indication, or long-term benefit relative to risk. We continuously reassess IV offerings to ensure they are justified, safe, and clinically sound.
Injectable Peptides (with One Exception)
Injectable peptides are a rapidly expanding category, many with limited human data and unclear risk profiles. Not to mention not Health Canada approved. For that reason, we do not offer injectable peptides broadly.
The exception is GLP-1–based therapies, which have substantial evidence, regulatory approval, and clearly defined indications when used appropriately.
What This Means for You as a Patient
It may mean:
You hear about something before we offer it
We say “not yet” when other clinics say “now”
We discontinue services when better data emerges
That is judgement. The kind you want in a provider.
Great cosmetic medicine is about doing what is right for the patient, at the right time, for the right reasons.
Our Philosophy, Clearly Stated
We do not chase trends.
We evaluate them.
We do not experiment on patients.
We protect them.
And we believe trust is built not by offering everything, but by knowing when not to.
If you ever have questions about why we do or do not offer a treatment, we welcome that conversation. Informed patients make better decisions. Thoughtful clinics make safer ones.
That is the standard we hold ourselves to.
Written by Madelaine Garcia, Chief Operating Officer, The Cosmetic Clinic